Working Group 1 is proud to announce the publication of two systematic reviews on the use of advanced MR imaging for high-grade glioma treatment response monitoring. Both reviews are published in the Frontiers in Oncology and can be downloaded here (Part 1: Perfusion and Diffusion) and here (Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics).
Both reviews result from impressive efforts by a WG1-team, led by Dr. Otto Henriksen (Rigshospitalet, Copenhagen) and Dr. Thomas Booth (KCL, London). Based on their findings, it appears that advanced MRI techniques show huge promise in treatment response assessment.
With these reviews, WG1 highlights that most monitoring biomarkers require standardized international consensus guidelines, with more facilitation regarding technique implementation and reporting in the clinic.
Finally, the reviews resulted in a press release from KCL, which has been picked up by several international news platforms. Congratulations to the whole team!
